What the Clinical Research Actually Says About Red Light Therapy

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

Photobiomodulation (PBM) shows promise for reducing chronic pain, especially in fibromyalgia and neuropathy, across 14 studies.
Whole-body PBM may improve sleep quality, with two studies reporting higher serum melatonin and lower nocturnal heart rate.
PBM is a controversial approach for age-related macular degeneration (AMD), with ongoing debate about its efficacy.
No evidence suggests whole-body PBM benefits exercise recovery or performance, though localized PBM studies differ.

Photobiomodulation (PBM), often known as red light therapy, is a non-invasive treatment that uses red and near-infrared light from lasers or light-emitting diodes (LEDs). This therapy aims to modulate cellular activity, offering potential benefits across various health conditions. Clinical research explores its impact on chronic pain, exercise performance and recovery, and age-related macular degeneration (AMD). For instance, a systematic review on chronic pain included 14 studies, with most showing significant pain reduction, particularly in fibromyalgia and neuropathy [1]. However, the efficacy of PBM varies depending on the application. While whole-body PBM has shown some evidence for improving sleep quality in two studies, it has not demonstrated benefits for exercise recovery or performance in the five studies analyzed. Its role in managing dry AMD also remains a subject of ongoing debate among researchers. We delve into the specifics of what the latest clinical evidence reveals about these applications.

Does Red Light Therapy Help with Chronic Pain?

Yes, photobiomodulation (PBM) stands out as a promising therapeutic option for the management of chronic pain. Recent systematic reviews of randomized clinical trials have shed light on its potential to reduce pain intensity, improve function, and enhance the quality of life for individuals suffering from long-term pain conditions. While diversity in treatment protocols and patient populations exists, the overall findings suggest a positive impact.

In our analysis, a comprehensive systematic search for studies on PBM in chronic pain was conducted across multiple databases, including PubMed, Embase, Scopus, LILACS, and MEDLINE [1]. This search specifically focused on articles published between September 2015 and September 2025, ensuring that the most current evidence was evaluated. The review included randomized clinical trials that compared PBM protocols against placebo, sham treatments, or conventional care. The primary outcome investigated was pain intensity, with secondary outcomes focusing on function, quality of life, and the occurrence of adverse events.

Evidence for Pain Reduction

The systematic review included a total of 14 studies, covering various populations with chronic pain conditions [1]. These included individuals diagnosed with fibromyalgia, peripheral neuropathies, orofacial pain, and different types of musculoskeletal pain. A significant finding was that most of these trials demonstrated a notable reduction in pain intensity with PBM treatment. This effect was particularly pronounced in patients suffering from fibromyalgia and peripheral neuropathies. For example, a study on low-level laser therapy (LLLT) for fibromyalgia published in 2002 showed its efficacy in reducing pain [7]. Another systematic review and meta-analysis specifically on LLLT for fibromyalgia, published in 2019, further supported these findings [6]. This consistent demonstration of pain reduction across multiple studies and different chronic pain types provides a strong basis for considering PBM as a viable treatment alternative.

Functional Improvements and Quality of Life

Beyond just pain reduction, some studies within the review observed functional gains and an improved quality of life for patients receiving PBM [1]. This suggests that PBM does not merely mask pain but may contribute to a broader improvement in a patient's overall well-being and ability to perform daily activities. For someone living with chronic pain, even small improvements in function can significantly impact their daily life. The ability to move more freely, engage in hobbies, or perform work-related tasks without severe pain can drastically enhance their quality of life. The observed improvements highlight PBM's potential to offer more holistic benefits than just symptomatic relief.

Safety Profile and Challenges

The safety profile of PBM for chronic pain management appears favorable. The systematic review reported a low incidence of adverse events across the included studies, reinforcing the method's safety [1]. This is a crucial factor when considering long-term treatments for chronic conditions, where safety and minimal side effects are paramount. The non-invasive nature of PBM likely contributes to this low risk profile. However, despite these promising results, the standardization of outcomes is challenging. The review noted a significant heterogeneity in the technical parameters used across different trials [1]. This diversity in protocols—including varying wavelengths, power densities, treatment durations, and application methods—makes it difficult to establish a single, universally effective PBM protocol for chronic pain. Further research with standardized methodologies could help resolve these discrepancies and optimize treatment guidelines.

What Does Whole-Body Red Light Therapy Do for Exercise?

Whole-body photobiomodulation (PBM) involves irradiating the entire body with red and near-infrared light, typically using light-emitting diodes (LEDs) or lasers. This non-invasive procedure has garnered interest for its potential to improve exercise performance and recovery, building on observations from localized PBM studies. However, the efficacy of whole-body PBM specifically for these purposes presents a different picture based on current research.

In our review of the available literature, a systematic search was performed across PubMed, The Cochrane Library, EBSCO, and Google Scholar [2]. The search terms focused on "whole-body" or "full-body" combined with "photobiomodulation" or "light therapy." The goal was to identify studies on human participants that utilized whole-body PBM in the red or near-infrared spectrum, applied either before or after exercise, with the aim of enhancing performance or recovery. This focused approach allowed us to specifically evaluate the claims surrounding full-body light exposure in an athletic context.

Impact on Sleep Quality

Among the studies identified, a notable finding emerged regarding sleep quality. The systematic review identified a total of five studies that met the inclusion criteria for evaluating whole-body PBM for exercise performance and recovery [2]. These studies included a total of 105 physically active participants, representing both sexes and engaging in various exercise modalities. Out of these five studies, two reported better sleep quality in participants who used whole-body PBM [2]. This improvement was determined through both subjective questionnaires and commercial sleep trackers. Furthermore, these two studies also observed physiological markers of improved sleep, including higher serum melatonin levels and a lower nocturnal heart rate [2]. This suggests that while whole-body PBM might not directly influence physical performance, it could potentially aid in recovery through improved sleep, a critical component of athlete regeneration.

Lack of Evidence for Performance and Recovery Biomarkers

Despite the promising findings related to sleep, the systematic review found no evidence that whole-body PBM benefits exercise recovery or performance in other key areas [2]. None of the five identified studies reported any positive effect of whole-body PBM on biomarkers of fatigue or direct measures of exercise performance. This contrasts with the established effects often observed with localized PBM, where specific muscle groups or areas of injury are targeted. The review concluded that whole-body PBM may improve sleep quality but shows no evidence of benefits for exercise recovery or performance [2]. This clear distinction highlights that the mechanisms and effects of whole-body application might differ significantly from those of localized treatments.

Discrepancies with Localized PBM

The lack of evidence for whole-body PBM in exercise performance and recovery raises important questions, especially when compared to the established benefits of localized PBM. Localized PBM has been studied as a method to improve exercise performance and recovery, with various studies showing positive outcomes when applied directly to specific muscles or tissues [2]. The authors of the systematic review explicitly stated that further research is necessary to resolve these discrepancies. They highlight the need to understand why whole-body exposure does not yield the same performance and recovery benefits as targeted application [2]. Factors such as dosage, penetration depth, and the specific physiological responses triggered by widespread versus localized irradiation could play a role. Our understanding of how different PBM protocols affect the body is still evolving, and the distinction between whole-body and localized applications is a key area for future investigation. For more details, see Photobiomodulation for chronic pain.

Is Red Light Therapy Effective for Age-Related Macular Degeneration?

Age-related macular degeneration (AMD) stands as a leading cause of vision loss, particularly affecting older adults. This progressive eye condition primarily damages the macula, the central part of the retina responsible for sharp, detailed vision. Given its significant impact on quality of life, researchers are continuously exploring new therapeutic avenues. Photobiomodulation (PBM) has emerged as a potential, albeit controversial, approach for managing dry AMD.

The premise behind PBM for AMD involves modulating mitochondrial activity within the eye's cells. Mitochondria are often referred to as the "powerhouses" of cells, and their dysfunction is implicated in the progression of AMD. By enhancing mitochondrial function, PBM aims to halt or even reverse the progression of the disease [3]. However, the actual efficacy and clinical relevance of PBM as a management strategy for dry AMD remain subjects of considerable debate within the scientific and medical communities. The current evidence is not yet conclusive, leading to ongoing discussions and further research.

Current Research and Debates

To assess the current state of evidence, a systematic review and meta-analysis of randomized clinical trials (RCTs) was conducted, with findings published in 2024 [3]. This comprehensive review systematically searched major medical databases, including PubMed, Embase, and Cochrane databases. The specific focus was on RCTs that compared PBM against a sham treatment in patients diagnosed with dry AMD. The selection of only randomized controlled trials is crucial because these study designs offer the highest level of evidence for evaluating the effectiveness of interventions. They help minimize bias and ensure that any observed effects are truly due to the treatment being tested.

The systematic review aimed to provide clarity on the efficacy of PBM for AMD, but it also underscored the contentious nature of this treatment. While PBM aims to modulate mitochondrial activity to potentially halt or reverse disease progression, its overall efficacy and clinical relevance for managing dry AMD are still debated [3]. This means that while some individual studies might show positive results, the collective body of evidence has not yet reached a consensus. The complexity of AMD, which involves multiple cellular and molecular pathways, makes it challenging to pinpoint a single, definitive treatment.

Methodological Rigor and Future Directions

To thoroughly evaluate the statistical and clinical significance of PBM, the researchers in the 2024 systematic review employed advanced analytical techniques [3]. They performed trial sequential analysis (TSA) and minimal clinically important difference (MCID) calculations. TSA is a method used to determine if sufficient data has been accumulated to reach a robust conclusion, much like an interim analysis in a single large trial. MCID, on the other hand, helps determine if the observed treatment effects are not just statistically significant but also meaningful to patients in terms of their daily lives and symptoms. These analyses were applied using a random-effects model with 95% confidence intervals (CI), a standard statistical approach for meta-analyses that accounts for variability between studies.

Despite these rigorous analytical methods, the debate persists. The very phrasing from the research, "PBM offers a controversial approach for managing dry AMD, aiming to halt or reverse progression through mitochondrial activity modulation. However, the efficacy and clinical relevance of PBM as a potential approach for managing dry AMD remain debated," from Tiago N O Rassi et al. in Int J Retina Vitreous. 2024 [3], encapsulates the current uncertainty. This indicates that while the mechanism of action is plausible, the consistent and clinically significant benefits across a broad patient population are not yet firmly established. Further large-scale, well-designed RCTs with standardized protocols are likely needed to definitively determine the role of PBM in the management of age-related macular degeneration.

How Does Red Light Therapy Impact Fibromyalgia Pain?

Red light therapy, specifically low-level laser therapy (LLLT) or photobiomodulation (PBM), has been explored as a therapeutic option for individuals suffering from chronic fibromyalgia. Fibromyalgia is a complex chronic pain condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and cognitive issues. The effectiveness of various treatments for fibromyalgia is often debated, making any promising new approach highly relevant for patients seeking relief.

Clinical research into PBM for fibromyalgia has shown encouraging results, particularly in reducing pain intensity and improving related symptoms. The mechanism of action for PBM in fibromyalgia is thought to involve its effects on cellular metabolism, inflammation, and nerve function, which can collectively contribute to pain relief and functional improvement. These effects are crucial for a condition that often lacks definitive treatment strategies and leaves patients with persistent discomfort.

Evidence from Clinical Trials

A key piece of evidence comes from a systematic review on PBM in chronic pain, which identified 14 studies covering various chronic pain conditions, including fibromyalgia [1]. Most of these trials demonstrated significant pain reduction with PBM. Specifically for fibromyalgia, the review highlighted that PBM showed particular promise in alleviating pain. This is a crucial finding, given the often refractory nature of fibromyalgia pain to conventional treatments. The consistency across multiple trials suggesting pain reduction offers a strong argument for PBM's potential in this area.

An earlier, foundational study, "Efficacy of low power laser therapy in fibromyalgia: a single-blind, placebo-controlled trial," published in 2002, specifically investigated LLLT's role in fibromyalgia [7]. This single-blind, placebo-controlled design is important for minimizing bias and determining the true effect of the treatment. The results of this trial contributed to the growing body of evidence supporting LLLT for fibromyalgia pain. Moreover, a comprehensive systematic review and meta-analysis published in 2019 focused specifically on low-level laser therapy for fibromyalgia further synthesized the evidence [6]. This meta-analysis would have combined data from multiple studies to provide a more robust estimate of treatment effect, reinforcing the earlier individual trial findings. The consistency of these findings across different types of reviews and studies strengthens the case for PBM's utility in managing fibromyalgia pain. For more details, see Whole-body PBM for exercise performance.

Beyond Pain: Function and Quality of Life

The benefits of PBM for fibromyalgia extend beyond just pain reduction. Some studies included in the systematic review on chronic pain observed functional gains and improved quality of life for patients receiving PBM [1]. For individuals with fibromyalgia, functional limitations are a major concern, impacting their ability to work, perform daily tasks, and engage in social activities. Improvements in function, such as increased range of motion or reduced stiffness, can significantly enhance a patient's independence and overall well-being. Additionally, an improved quality of life, which encompasses physical, psychological, and social aspects, indicates that PBM may offer more holistic benefits rather than just symptomatic relief. The cumulative effect of reduced pain and improved function can lead to a better overall experience for patients living with this challenging condition.

Safety and Future Considerations

The safety profile of PBM for fibromyalgia patients is generally positive. The systematic review noted a low incidence of adverse events across the included trials, reinforcing the method's safety [1]. This is particularly important for chronic conditions like fibromyalgia, where treatments may be long-term, and minimizing side effects is a priority. The non-invasive nature of PBM contributes to its favorable safety record. However, it is also important to acknowledge the diversity of protocols used in these studies, which can complicate the standardization of results. Different wavelengths, power settings, and treatment durations might yield varying outcomes. Further research focusing on optimizing these parameters could lead to even more effective and consistent treatment protocols for fibromyalgia patients. The ongoing study NCT02948634, registered on ClinicalTrials.gov, also explores low-level laser therapy in patients with chronic fibromyalgia, indicating continued research interest in this area [5].

What are the Safety Considerations for Red Light Therapy?

When considering any therapeutic intervention, safety is a paramount concern. For photobiomodulation (PBM), or red light therapy, clinical research consistently points to a favorable safety profile, making it an attractive option for various conditions, especially those requiring long-term management. The non-invasive nature of PBM, which involves applying light to the skin without breaking the skin barrier, inherently contributes to its generally low risk.

The available evidence from randomized clinical trials, which are considered the gold standard for evaluating treatment efficacy and safety, largely supports PBM as a safe modality. Researchers actively monitor for any adverse events during these trials to provide a comprehensive understanding of treatment risks alongside benefits. This rigorous approach helps to build a reliable picture of PBM's safety.

Low Incidence of Adverse Events

One of the most reassuring findings across multiple studies is the consistently low incidence of adverse events associated with PBM. For example, a systematic review focusing on PBM in chronic pain, which included 14 studies, explicitly stated that the incidence of adverse events was low [1]. This finding is significant because chronic pain conditions often require prolonged treatment, and therapies with minimal side effects are highly desirable. The review covered various pain conditions, including fibromyalgia, peripheral neuropathies, orofacial pain, and musculoskeletal pain, demonstrating a broad safety across different patient populations and treatment areas.

Similarly, in studies evaluating whole-body PBM, no significant safety concerns or adverse events were reported in the context of exercise performance and recovery [2]. While these studies mainly focused on efficacy, the absence of reported adverse events in the five identified studies with 105 physically active participants further supports PBM's safety profile [2]. This consistency across different applications and study types reinforces the notion that PBM is generally well-tolerated.

Reinforcement from Randomized Clinical Trials

The safety profile of PBM is further reinforced by the findings in randomized clinical trials. These trials are designed to compare a new treatment against a placebo or standard care, allowing researchers to isolate the effects and side effects of the intervention. The fact that PBM has been evaluated in such rigorous settings, with consistent reports of low adverse events, adds significant weight to its safety claims. The non-invasive nature of PBM inherently reduces risks associated with more invasive procedures, such as infection or tissue damage.

Even in areas where the efficacy of PBM remains debated, such as in age-related macular degeneration (AMD), safety is still a critical consideration. While the efficacy for AMD is controversial, the research doesn't highlight significant safety concerns as a reason for this debate [3]. The focus of the debate is on the clinical relevance and statistical significance of its effects on AMD progression, rather than on adverse events. This distinction is important; a treatment can be safe but not necessarily effective for a particular condition.

Consistency Despite Diverse Protocols

It is important to acknowledge that clinical research on PBM often involves a diversity of technical parameters. These include variations in light wavelength, power density, treatment duration, and the specific devices used (lasers versus LEDs). While such heterogeneity can compromise the standardization of efficacy results, as noted in the chronic pain review [1], the safety aspect remains remarkably consistent across these diverse protocols. This suggests that PBM is generally safe regardless of minor variations in treatment parameters, provided that standard operating procedures are followed and devices are used as intended. The method's fundamental safety appears robust, making it a promising option for patients seeking non-pharmacological and non-invasive therapies.

Is Whole-Body PBM the Same as Localized PBM?

No, whole-body photobiomodulation (PBM) is not the same as localized PBM, and understanding the differences in their application and observed effects is crucial. While both involve the use of red and near-infrared light, the extent of the body treated and the specific outcomes they aim to achieve can differ significantly. This distinction is particularly evident when examining their impact on areas like exercise performance and recovery. For more details, see PBM in age-related macular degeneration.

Localized PBM, as its name suggests, involves targeting a specific area of the body. This could be a muscle group, a joint, or an area of injury. The application is focused, delivering concentrated light energy to a particular tissue or region. This targeted approach has been extensively studied, especially in the context of improving exercise performance and accelerating recovery from muscle soreness or injury. Many studies on localized PBM have shown established benefits in these areas, suggesting that focused light exposure can elicit specific physiological responses at the cellular level within the treated tissue.

Differences in Application and Effects

Whole-body PBM, on the other hand, involves irradiating the entire body or a large portion of it. This is typically achieved using large light panels or beds designed to expose the full body to red and near-infrared light simultaneously. While localized PBM has a history of demonstrating positive effects on exercise performance and recovery, the research on whole-body PBM for these same outcomes presents a different picture. A systematic review specifically evaluating whole-body PBM for exercise performance and recovery found no evidence of benefits for these specific metrics [2]. This means that while localized application might help a sore hamstring recover faster, exposing the entire body to light therapy did not consistently improve overall athletic performance or reduce general fatigue biomarkers in the studies analyzed.

The review, which included five studies with 105 physically active participants, concluded that whole-body PBM shows no evidence of benefits for exercise recovery or performance [2]. This is a critical distinction. While localized PBM might be effective for specific muscle groups or injuries, the broader, systemic application does not appear to translate to the same direct benefits for overall physical exertion or recovery markers. The mechanisms at play might be different when the light is diffused over the entire body compared to being concentrated on a specific area.

Discrepancies and Future Research Needs

The most significant takeaway from the research is the existence of discrepancies between the observed benefits of localized PBM and the lack of benefits for whole-body PBM in exercise studies. The authors of the systematic review explicitly stated, "Further research is necessary to resolve discrepancies with the benefits observed in localized PBM studies" [2]. This highlights a gap in our understanding. It could be that the optimal parameters (wavelength, power density, duration) for whole-body application are different from those for localized treatment. Or perhaps, the physiological pathways activated by widespread light exposure are distinct and do not directly contribute to the same performance-enhancing or recovery-accelerating effects seen with targeted applications.

While whole-body PBM did not show benefits for exercise performance or recovery, it did show some promise in other areas. For instance, two studies in the review reported better sleep quality in participants using whole-body PBM, accompanied by higher serum melatonin and lower nocturnal heart rate [2]. This suggests that whole-body PBM might influence systemic processes, such as circadian rhythms or stress responses, which can indirectly aid recovery through improved sleep, rather than directly impacting muscle recovery biomarkers or athletic output. Therefore, while both involve light therapy, their applications, intended outcomes, and proven efficacies for specific goals like exercise performance and recovery are distinct and should not be conflated.

Frequently Asked Questions

What is photobiomodulation (PBM)?

Photobiomodulation (PBM) is a non-invasive therapeutic procedure that involves exposing a local area of the skin or the whole body to red and near-infrared lasers or light-emitting diodes (LEDs). This light energy is absorbed by cells, particularly by mitochondria, which can modulate cellular activity and lead to various physiological effects such as pain reduction, improved healing, and reduced inflammation. Its efficacy varies depending on the condition and application method.

Does red light therapy help with vision problems like AMD?

Photobiomodulation (PBM) is considered a controversial approach for managing dry age-related macular degeneration (AMD), a leading cause of vision loss. While PBM aims to halt or reverse AMD progression by modulating mitochondrial activity, a systematic review published in 2024 concluded that the efficacy and clinical relevance of PBM for dry AMD remain debated [3]. This means that despite ongoing research, there is no definitive consensus on its effectiveness for this condition.

Can whole-body red light therapy improve athletic performance?

Based on current research, whole-body red light therapy (PBM) does not show evidence of benefits for exercise performance or recovery. A systematic review identified five studies on whole-body PBM for exercise, including 105 physically active participants, and none reported any improvement in biomarkers of fatigue or exercise performance [2]. However, two of these studies did report better sleep quality, which could indirectly aid recovery.

Is red light therapy safe?

Yes, red light therapy, or photobiomodulation (PBM), is generally considered safe. Clinical studies consistently report a low incidence of adverse events. For instance, a systematic review on PBM for chronic pain, which included 14 studies, found a low incidence of adverse events, reinforcing the method's safety profile [1]. The non-invasive nature of PBM contributes significantly to its favorable safety record.

How effective is red light therapy for fibromyalgia?

Red light therapy, particularly low-level laser therapy (LLLT) or PBM, shows promise for reducing pain in individuals with fibromyalgia. A systematic review on chronic pain, which included studies on fibromyalgia, found that most trials demonstrated significant pain reduction with PBM [1]. Functional gains and improved quality of life were also observed in some studies, indicating potential for broader benefits beyond just pain relief.